Borylation via Iridium catalysed C-H activation: a new concise route to duocarmycin derivatives

24 April 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The synthesis of the ethyl ester analogue of the ultapotent antitumour antibiotic seco-duocarmycin SA has been achieved in eleven linear steps from commercially available starting materials. The DSA alkylation subunit can be made in ten linear steps from the same precursor. The route involves CH activation at the equivalent of the C7 position on indole leading to a borylated intermediate 9 that is stable enough for coupling reactions but can be easily converted to the free hydroxyl analogue.

Keywords

duocarmycin
synthesis
medicinal chemistry
DNA binding ligand
anticancer activity

Supplementary materials

Title
Description
Actions
Title
Supporting Information -Borylation via Iridium catalysed C-H activation: a new concise route to duocarmycin derivatives
Description
Supporting information including general methods, synthetic details, analysis of compounds and copies of NMR spectra.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.